Mitochondria-associated endoplasmic reticulum membranes as a therapeutic target for cardiovascular diseases
Frontiers in Pharmacology · 17.04.2024 · 15
DOI: 10.3389/fphar.2024.1398381 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.04.2024. Verfasst von Yanqiu Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are currently the leading cause of death worldwide. In 2022, the CVDs contributed to 19.8 million deaths globally, accounting for one-third of all global deaths. With an aging population and changing lifestyles, CVDs pose a major threat to human health. Mitochondria-associated endoplasmic reticulum membranes (MAMs) are communication platforms between cellular organelles and regulate cellular physiological functions, including apoptosis, autophagy, and programmed necrosis. Further research has shown that MAMs play a critical role in the pathogenesis of CVDs, including myocardial ischemia and reperfusion injury, heart failure, pulmonary hypertension, and coronary atherosclerosis. This suggests that MAMs could be an important therapeutic target for managing CVDs. The goal of this study is to summarize the protein complex of MAMs, discuss its role in the pathological mechanisms of CVDs in terms of its functions such as Ca 2+ transport, apoptotic signaling, and lipid metabolism, and suggest the possibility of MAMs as a potential therapeutic approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Graduate School, Beijing University of Chinese Medicine, Beijing, China.
- Department of Geratology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zitieren
APA
Ding, Y., Liu, N., Zhang, D., Guo, L., Shang, Q., Liu, Y., Ren, G., & Ma, X. (2024). Mitochondria-associated endoplasmic reticulum membranes as a therapeutic target for cardiovascular diseases. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1398381
Vancouver
Ding Y, Liu N, Zhang D, Guo L, Shang Q, Liu Y, et al. Mitochondria-associated endoplasmic reticulum membranes as a therapeutic target for cardiovascular diseases. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1398381
BibTeX
@article{Ding2024,
author = {Ding, Yanqiu and Liu, Nanyang and Zhang, Dawu and Guo, Lijun and Shang, Qinghua and Liu, Yicheng and Ren, Gaocan and Ma, Xiaochang},
title = {Mitochondria-associated endoplasmic reticulum membranes as a therapeutic target for cardiovascular diseases},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1398381}
}
EUVIMED